Abstract
Neutral sphingomyelinase (N-SMase) elevated nitric oxide (NO) production without affecting intracellular Ca(2+) concentration ([Ca(2+)](i)) in endothelial cells in situ on aortic valves, and induced prominent endothelium-dependent relaxation of coronary arteries, which was blocked by N(omega)-monomethyl-L-arginine, a NO synthase (NOS) inhibitor. N-SMase induced translocation of endothelial NOS (eNOS) from plasma membrane caveolae to intracellular region, eNOS phosphorylation on serine 1179, and an increase of ceramide level in endothelial cells. Membrane-permeable ceramide (C(8)-ceramide) mimicked the responses to N-SMase. We propose the involvement of N-SMase and ceramide in Ca(2+)-independent eNOS activation and NO production in endothelial cells in situ, linking to endothelium-dependent vasorelaxation.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Aorta / cytology
-
Calcium / metabolism
-
Cattle
-
Caveolae / drug effects
-
Caveolae / physiology
-
Caveolin 1
-
Caveolins / analysis
-
Ceramides / metabolism
-
Coronary Vessels / drug effects
-
Cytosol / chemistry
-
Cytosol / metabolism
-
Endothelium, Vascular / drug effects
-
Endothelium, Vascular / physiology*
-
Nitric Oxide / biosynthesis*
-
Nitric Oxide Synthase / analysis
-
Nitric Oxide Synthase / metabolism*
-
Nitric Oxide Synthase Type III
-
Phosphorylation
-
Protein Transport / drug effects
-
Sphingomyelin Phosphodiesterase / pharmacology*
-
Sphingosine / analogs & derivatives*
-
Sphingosine / pharmacology
-
Vasodilation*
Substances
-
2,3-N-octanoylsphingosine
-
Caveolin 1
-
Caveolins
-
Ceramides
-
Nitric Oxide
-
N-palmitoylsphingosine
-
Nitric Oxide Synthase
-
Nitric Oxide Synthase Type III
-
Sphingomyelin Phosphodiesterase
-
Sphingosine
-
Calcium